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Abstract
One hundred and fifteen patients with symptoms suggestive of irritable bowel syndrome (IBS) according to Rome
III criteria and 209 patients with gastrointestinal symptoms different from IBS (control) were identified through
medical records from the Gastroenterology Clinic of the “Dr. Manuel Gea Gonzalez General Hospital” from January
2008 to March 2010. No statistical differences in IBS data as compared with control groups were observed except
in bloating, that was more frequent in the IBS group (P = 0.043). Although the pathogenicity of specific intestinal
protozoa could not be demonstrated due to lack of association with the development of gastrointestinal
symptoms, Blastocystis spp, in the IBS group, exhibited a trend of association to diarrhoea (odds ratio = 2.73, 95%
confidence interval = 0.84-8.80, P = 0.053), while having any parasite and diarrhoea was significant (odds ratio =
3.38, 95% confidence interval = 1.33-8.57, P = 0.008). The association between Blastocystis and diarrhoea in IBS
patients although not conclusive is an interesting finding; nonetheless more extensive case-controlled studies are
required to clearly define the role of some “non-pathogenic” parasites in intestinal disease and IBS.
Findings
In recent times, some common “non-pathogenic” para-
sites such as Blastocystis hominis and Diantamoeba fra-
gilis have been associated with abdominal pain, bloating,
and alteration of bowel habits resembling irritable bowel
syndrome (IBS) [1,2]. IBS is a functional bowel disorder
in which abdominal pain or discomfort is associated
with defecation disorders [3]. IBS is a frequent disease
in clinical practice, representing 12% of all diagnoses
obtained in general medical visits and 25% to 50% of all
gastroenterology consultations [3,4]. The objective of
the present study was to determine the role of intestinal
protozoa among IBS patients and to analyze the clinical
course of the disease.
Individuals who had attended the gastroenterology
clinic of the “Dr. Manuel Gea Gonzalez General Hospi-
tal” between January 2008 and March 2010 were identi-
fied from the database of medical records. The study
was reviewed and approved by the Ethical and Research
Committee of the hospital. Cases were defined as
patients with symptoms of IBS according to the Rome
III criteria. Such symptoms would consist of recurrent
abdominal pain or uncomfortable sensation at least 3
days per month in the last 3 months associated with 2
or more of the following: i) improvement with defeca-
tion, ii) onset associated with a change in frequency of
stool release, iii) onset associated with a change in form
or appearance of stools [3]. The control group consisted
of individuals without diagnosis of IBS but with other
physiological alterations and gastrointestinal symptoms
i.e., polypus, diabetes, haemorrhoids, ulcerative colitis,
etc. Coprological studies were performed using Faust’s
technique with three faecal samples [5,6]. Descriptive
statistics were expressed as mean and standard deviation
(SD). Variables were analyzed by c
2 tests for categorical
variables; odds ratio and confidence interval were also
obtained. Data analysis was performed with SSPS Ver-
sion 15.0 for Windows (SPSS Institute, Chicago, IL).
A total of 253 female and 112 male patient records
were analyzed during the two-year study period. The
mean age was 52 (SD = 15) years; all patients resided in
urban areas. Table 1 shows the results and a statistical
analysis of clinical signs and symptoms and parasites in
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in both groups were observed except in bloating, that
was more frequent in IBS patients (P = 0.043). In both
groups, abdominal pain and constipation were in general
the predominant symptoms (84% and 62% respectively)
and Blastocystis, Endolimax nana and Entamoeba histo-
lytica/dispar w e r et h em o s tf r e q u e n tp a r a s i t e s( 2 1 % ,
13%, and 7% respectively). Group analysis showed a sig-
nificant association between having any parasite and
diarrhoea in IBS patients, while Blastocystis exhibited a
trend of association with diarrhoea in the same group
(Table 2). In all the parasitized patients, stool was exam-
ined before treatment with the drug nitazoxanide
according to Diaz et al. [7].
There are no previous clear reports about association
between IBS and parasites in Latin American patients.
Our results show that the overall prevalence of intestinal
protozoa in Mexican IBS patients was 23% (Blastocystis
spp in 16%, E. nana in 9% and E. histolytica/dispar in
3%), these findings suggest an association between IBS
and Blastocystis. A prior study by Yamamoto-Furusho
and Torijano-Carrera [8] explored the prevalence of
intestinal protozoa in Mexican patients from urban
areas with ulcerative colitis and found a prevalence of
24% for intestinal protozoa (Blastocystis spp 10%,
E. nana 9% and E. histolytica 5%); in the present study
and in Yamamoto-Furusho’so n e ,Blastocystis was the
most frequent parasite, in spite of the fact that in both
studies different diagnostic techniques (trichrome-stain-
ing and concentration by flotation, respectively) were
used. Yakoob et al. [9] demonstrated that faecal carriage
of B. hominis occurred more frequently in Pakistani
patients with IBS (46%) than the control group (7%). In
contrast, Tungtrongchitr et al. [10] found no association
between faecal carriage of Blastocystis and IBS in Thai-
land participants.
According to some researchers [5,11], Blastocystis is
currently the main dominant parasite found in human
stool samples; it may have displaced other protozoa due
the reluctance of physicians to treat the infection, as
symptoms are self-limiting, and its pathogenicity has
been considered as controversial. An additional factor
leading to Blastocystis’ dominance may be that this
microorganism has developed resistance to antiparasitic
drugs which treat pathogenic protozoa. Following con-
ventional treatment, intestinal empty niches may be
easily colonized by Blastocystis spp. Finally, similar to
other intestinal protozoa, the presence of deficient
hygienic habits and lack of health education programs
increase the prevalence of this parasite.
Studies into the clinical significance of Blastocystis
may be influenced by the sensitivity of detection meth-
ods. Conventionally, it is detected using standardized
clinical coprological methods, which are also used to
detect other enteric parasites [12]. Faecal concentration,
direct smears and staining have been used by several
authors to detect the presence of Blastocystis,a l t h o u g h
those methods have been shown to have a low sensitiv-
ity [11,12], Recently, amplification of specific DNA
directly from faeces provides a significantly higher sensi-
tivity than concentration techniques and is 100% specific
[12,13], although this molecular technique is not com-
monly available in developing countries.
The pathophysiology of IBS remains elusive because
no mechanism is unique to, or characteristic of IBS.
There are no firm recommendations about the extent
and type of testing required to exclude other pathologies
in this disease; investigation of stool for ova, cysts and
Table 1 Demographic, clinical characteristics and
parasites in IBS patients and in the control group
Characteristic Frequency
IBS group Control group P value
Age at diagnosis, years 51 ± 15 53 ± 15 0.482
Female/male, n 91/24 162/47 0.736
Clinical symptoms, %
Abdominal pain 81.7 85.6 0.355
Bloating 84.3 74.6 0.043
Constipation 65.2 60.3 0.381
Diarrhoea 26.1 28.2 0.679
Flatulence 12.2 10.0 0.555
Diarrhoea-Constipation 8.7 5.3 0.229
Parasites found, %
Any parasite 22.6 19.6 0.524
Blastocystis spp 15.7 12.0 0.348
Endolimax nana 8.7 6.7 0.511
Entamoeba histolytica/dispar 2.6 2.9 0.890
Giardia lamblia 1.7 1.4 0.831
Co-infection with 2 parasites 6.0 3.4 0.246
Table 2 Association between having any protozoan
parasite or Blastocystis and diarrhoea
Group (n) Variable OR* 95%IC‡ c
2 P
value
IBS group (115) Any parasite/
Diarrhoea
3.38 1.33-8.57 7.02 0.008
Blastocystis/
Diarrhoea
2.73 0.84-8.80 3.74 0.053
Control group
(209)
Any parasite/
Diarrhoea
0.783 0.36-1.72 0.37 0.542
Blastocystis/
Diarrhoea
0.781 0.29-2.06 0.25 0.617
All participants
(324)
Any parasite/
Diarrhoea
1.39 0.77-2.48 1.22 0.269
Blastocystis/
Diarrhoea
1.33 0.62-2.8 0.64 0.420
*OR, Odds ratio; ‡95%IC, 95% Confidence interval.
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the major manifestation of IBS, but the role that proto-
zoan parasites may play in this complex disease has not
been fully investigated [1,3,14]. Furthermore, prior stu-
dies had found that IBS patients exhibit certain genetic
polymorphisms related to IL-10, TNF-alpha, IL-4, and
serotonin [15,16]; thus, we can hypothesize that when
patients with certain cytokine gene polymorphisms are
infected with Blastocystis, they are more likely to
develop diarrhoea. Although our results showed a trend
of association between this parasite and diarrhoea in IBS
patients, more extensive case-control studies that
include parasitological molecular diagnostic techniques
and genetic profiles of pro-inflammatory cytokines are
required to clearly define the potential role of “non-
pathogenic” intestinal parasites.
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